Lecture 7: Diabetes Flashcards

1
Q

Why is glucose so toxic

  • Hyperglycemia leads to ___ modification of proteins
  • oxidation products of glucose react ___ with proteins to form ___ (AGE)
  • loss of normal ___ function
  • acceleration of ___ process
  • theorized to account for many ___ complications of diabetes
A
  • covalent
  • irreversibly, Advanced Glycation End-products
  • protein
  • aging
  • long term
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hyperglycemia: covalent modification of proteins

Peptides containing ___ and ___ bind to RAGE and promote inflammation

A

CML and CEL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

mechanisms of cell damage initiated by hyperglycemia

  • glucose follows the ____ pathway
  • fructose-6-P follows the ___ pathway
  • glyceraldehyde-3-P → DAG follows the ___ pathway
  • glyceraldehyde-3-P → methylglyoxal follows the ___ pathway
A
  • Polyol
  • Hexosamine
  • Protein kinase C
  • AGE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mechanisms of cell damage initiated by hyperglycemia

when glucose increased, ___ accumulates leading to the Hexosamine pathway

A

fructose-6-P

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

AGE precursor ____ inhibits vasorelaxation stimulated by ___ / ___

A
  • methylglyoxal
  • acetylcholine/nitric oxide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The insulin receptor

role of alpha subunits
- regulatory: repress the ___ activity of beta subunit
- repression is relieved by ___ binding

role of beta subunits
- contains ___ cataytic domains
- auto___

A
  • catalyic
  • insulin
  • tyrosine kinase
  • autophosphorylation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Insulin Membrane Receptor

1) insulin binds, and activates intracellular ___ domain
2) the receptor is then ___
3) ___ is recruited to receptor and ___
4) ___ is recruited to the complex and phosphorylates ___ into PIP3
5) PIP3 activates ___ which increases ___ , ___ synthesis, and ___ uptake and decreases ___
6) IRS also increases ___ for cell growth, proliferation, and increased DNA/RNA synthesis

A

1) tyrosine kinase
2) autophosphorylated
3) IRS, phosphorylated
4) P13K, PIP2
5) PDK1, glycolysis, glycogen, glucose, gluconeogenesis
6) lipogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Insulin Effects on Various Tissues - Liver

inhibits:
- ___olysis
- ___genesis
- ___genesis

stimulates:
- ___ and ___ synthesis

A
  • glycogenolysis
  • ketogenesis
  • gluconeogenesis
  • glycogen, triglyceride
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Insulin Effects on Various Tissues - Skeletal Muscle

stimulates:
- ___ and ___ transport

A

glucose, amino acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Insulin Effects on Various Tissues - Adipose Tissue

stimulates:
- ___ storage
- ___ transport

A
  • triglyceride
  • glucose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

glucose disposal

Fasting
- ___% is non-insulin-dependent (liver, GI, brain)
- ___ % is insulin-dependent in skeletal muscle
- ___ is secreted to prevent hypoglycemia

A

75%
25%
glucagon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

glucose disposal

Fed
- ___% is insulin-dependent in skeletal muscle
- ___% is insulin-dependent in adipose tissue
- ___ secretion inhibited
- insulin inhibits release of ___ from adpose tissue
- decreases serum ___
- enhances insulin action on ___
- reduces ___ glucose production

A
  • 80-85%
  • 4-5%
  • glucagon
  • FFA
  • FFA
  • skeletal muscle
  • hepatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Glucose transporters

  • GLUT1: Km - ___ mM Location: ___
  • GLUT2: Km - ___ mM Location: ___
  • GLUT3: Km - < ___ mM Location: ___
  • GLUT4: Km - ___ mM Location: ___

GLUT4 is ___ and all others are ___

A
  • 1-2, widely expressed in beta cells (?)
  • 15-20, beta cells, liver
  • 1, neurons
  • 5, skel. muscle, adipocytes

insulin-induced, constitutive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why are GLUT2 transporters less sensitive (Km 15-20)?

A

dont want to make insulin when theres only a little glucose around

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why are GLUT3 transporters super sensitive (Km < 1 mM)?

A

nerves need to eat it up. glucose is fuel for the neurons z

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which GLUT is insulin-induced

A

GLUT 4

17
Q

Pancreas - Site of Insulin production and secretion

islet of ___

A

Langerhans

18
Q

Actions of pancreatic polypeptide hormones

glucagon
- stimulates ___ breakdown
- increases blood ___

somatostatin
- general inhibitor of ___

insulin
- stimulates uptake and utilization of ___

amylin
- co-secreted with ___
- slows ___ emptying
- decreases ___ intake
- inhibits ___ secretion

A
  • glycogen
  • gluocse
  • secretion
  • glucose
  • insulin
  • gastric
  • food
  • glucagon
19
Q

Insulin processing

insulin synthesis in the ___ cell
- synthesized as a single ___ and deposited in secretory ___
- it is then cleaved by ___ into A and B chains and C ( ___ ) peptide

A

beta
- peptide, granules
- proconvertase, connecting

20
Q

Insulin granules

electron micrograph image shows dark areas where there is high concentrations of ___

A

Zn transporters

Zn condenses insulin into dense core

21
Q

Recombinant human insulin

  • E. coli: ___ (Lilly)
  • Transformed ___: Novolin (Novo Nordisk)
A
  • Humulin
  • Yeast
22
Q

Ultra Rapid Onset Insulin

A
  • Lispro (Humalog)
  • Aspart (Novolog)
  • Glulisine (Apidra)
23
Q

Slow Onset/Long Action Insulin

A
  • Glargine (Lantus)
  • Detemir (Levemir)
  • Degludec (Tresiba)
24
Q

Mimicking natural insulin secretion pattern

modified insulins alter the availability and ___ from subcutaneous injection sites

A

absorption

25
Q

Insoluble insulin complexes

the “lente” insulins - Zn/insulin precipitates
- larger complex size - prolonged absorption
- dimers catalyzed to form ___ of dimers (hexamer)
- semilente - small amorphous particles (non-___)
- lente - small amorphous and large crystalline complexes. ___ absorbed, long acting
- ultralente - only ___ crystalline complexes - very slowly absorbed, very long acting

“lente” insulins are no longer used therapeutically

A
  • trimer
  • crystalline
  • slowly
  • large
26
Q

insoluble insulin complexes

NPH = ___
slow absorption, long duration of action
- insulin is bound to ___ , tissue proteases free up the insulin

A
  • Neutral Protamine Hagedorn
  • protamine
27
Q

mutated human insulins

Lispro insulin (___)
1) reversing positions of ___ and ___ on insulin B chain results in decreased ___
2) insulin dimer and ___ formation
3) onset: ___ min
4) injected immediately ____ meals

A

Humalog
- P28, K29, self-association
- hexamer
- 5-15 min
- before

28
Q

mutated human insulins

insulin Aspart (___)
human, except proline 28 in B chain is switched to ___
- rapid onset: ___ min short duration
- injected immediately before ___

A

Novolog
- aspartate
- 5-15 min
- meals

29
Q

mutated human insulins

Insulin Glulisine (___)
human, except Asn 3 and Lys 29 in B chain are switched to ___ and ___
- rapid onset: ___ min, short duration
- injected immediately before ___

A

Apidra
Lys, Glu
- 5-15
- meals

30
Q

Mutated human insulin

Insulin Glargine (___)
- Asn 21 of A-chain is changed to ___
- 2 ___ residues added to the end of the B-chain (30 and 31)
- pH of ___ , ___ when neutralized
- slowly released from injection site over 24 hours
- ___ daily injection
- no pronounced ___

A

Lantus
- Gly
- Arg
- 4, precipitates
- once
- peak

31
Q

Mutated human insulins

Insulin Detemir (___)
- Thr 30 of B-chain is ___, and Lys 29 is ___
- binds serum ___ extensively
- injected once or twice daily

A

Levemir
- deleted
- myristylated
albumin

32
Q

Mutated human insulins

Insulin Degludec (___)
- Thr 30 of B-chain is replaced by gamma-Glu/C16 ___
- binds serum ___ extensively
- clear solution - injected ___ daily

A

Tresiba
- fatty acid
- albumin
- once

33
Q

Common Multi-Dosing Insulin Regimens

Fast onset, short acting taken ___ meals

Long, or intermediate acting taken at bedtime or at bedtime and ___ breakfast

A
  • before
  • after
34
Q

Mixture

NPH + regular
Humulin ___ and ___

NPL (___) + Lispro
Humalog ___ and ___

Ryzodeg (70% ___ + 30% ___ )

These give a transient preprandial bolus and prolonged basal level in a ____ injection

A
  • 70/30 and 50/50
  • 75/25 and 50/50
  • Degludec, aspart
  • single
35
Q

Inhaled insulin

Afrezza
___ onset, shorter duration of action than ___ - used as pre-prandial insulin
- contraindicated in pts with ___ and ___

A

rapid, SC injection
- COPD, asthma

36
Q

routes of administration

  • subcutaneous - all preparations
  • Insulin infusion pump - Buffered ___ also rapidly acting ( ___, ___, ___)
  • IV - ___ (for severe hyperglycemia or ketoacidosis)
  • Inhalation - ___
A
  • Regular, Lispro, Aspart, Glulisine
  • Regular
  • Afrezza
37
Q

Therapeutic uses of insulin

Indications
1) ___ diabetics
2) ketosis and ___ coma
3) some ___ diabetics

Mode of action
1) decreased ___ glucose output
2) increase ___ storage
3) increase ___ uptake

A
  • type I
  • hyperosmolar
  • type II
  • liver
  • fat
  • glucose